Markers of apoptosis and cellular death in patients on chronic hemodialysis.

被引：0
|
作者：
Soubassi, LP
Sarandakou, A
Kotsis, B
Chaniotis, DI
Zerefos, SN
Soubassi, SP
Zerefos, NS
机构：
[1] Univ Athens, Dept Clin Therapeut, Athens, Greece
[2] Aretaieion Univ Athens, Hormone Lab, Athens, Greece
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2002年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [1] Survival analysis of patients undergoing chronic hemodialysis.
    Kim, SS
    Kim, JS
    Kim, JH
    Hwang, PJ
    Na, GR
    Oh, SM
    Bin, KT
    Lee, KW
    Han, MH
    Lee, KS
    Sin, YT
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (05) : 1802 - 1802
  • [2] Predictors of stroke in patients receiving chronic hemodialysis.
    Iseki, K
    Fukiyama, K
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1169 - A1169
  • [3] Tips for patients with refractory ascites and chronic hemodialysis.
    Ochs, A
    Rossle, M
    Haag, K
    Piotraschke, J
    Schollmeyer, P
    Blum, HE
    [J]. HEPATOLOGY, 1996, 24 (04) : 1275 - 1275
  • [4] Cellular activation and apoptosis as markers of inflammation induced by hemodialysis
    Carracedo, J
    Ramírez, R
    Madueño, JA
    Soriano, S
    Rodríguez-Benot, A
    Rodríguez, M
    Martín-Malo, A
    Aljama, P
    [J]. NEFROLOGIA, 2001, 21 : 40 - 44
  • [5] Plasma isoprostanes markers of oxidative stress in patients on long term hemodialysis.
    Walter, MF
    Levin, NW
    Nightingale, ZD
    Handelman, GJ
    [J]. FASEB JOURNAL, 1999, 13 (04): : A564 - A564
  • [6] Low levels of antioxidant defenses in chronic renal patients in hemodialysis.
    deCavanagh, EMV
    Carrasquedo, F
    Scrivo, D
    Wassermann, A
    Fraga, CG
    Ferder, L
    Inserra, F
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1070 - A1070
  • [7] Telavancin pharmacokinetics in patients with chronic kidney disease receiving hemodialysis.
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E256 - E256
  • [8] Development of an HCV risk stratification algorithm for patients on chronic hemodialysis.
    Ma, WL
    Rossi, S
    Michael, B
    Dunn, S
    Hyslop, T
    Herrine, SK
    [J]. HEPATOLOGY, 2001, 34 (04) : 574A - 574A
  • [9] Diastolic dysfunction in chronic renal failure patients under hemodialysis.
    Douchet, MP
    Couppie, P
    Chantrel, F
    Kuntz, C
    Hannedouche, T
    [J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1996, 45 (10): : 589 - 592
  • [10] EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS
    Kirmizis, D.
    Papagianni, A.
    Belechri, A-M
    Efstratiadis, G.
    Alexopoulos, E.
    Memmos, D.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345